Related references
Note: Only part of the references are listed.Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus:: Novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress
Tobias Welt et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder
Angelika Erhardt et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice
A Keeney et al.
JOURNAL OF NEUROENDOCRINOLOGY (2006)
Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects
Z Merali et al.
BIOLOGICAL PSYCHIATRY (2006)
Changes in hypothalamic-pituitary-adrenal function, body temperature, body weight and food intake with repeated social stress exposure in rats
S Bhatnagar et al.
JOURNAL OF NEUROENDOCRINOLOGY (2006)
NBI 30775 (R121919), an orally active antagonist of the corticotropin-releasing factor (CRF) type-1 receptor for the treatment of anxiety and depression
C Chen et al.
DRUG DEVELOPMENT RESEARCH (2005)
Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919)
A Post et al.
PSYCHOPHARMACOLOGY (2005)
Stress and the brain:: From adaptation to disease
ER de Kloet et al.
NATURE REVIEWS NEUROSCIENCE (2005)
The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression - A replication
KS Kendler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders
ME Keck et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Treatment with the C RH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression
K Held et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2004)
Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylamino-pyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure-activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists
C Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress
MB Müller et al.
NATURE NEUROSCIENCE (2003)
Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene
A Caspi et al.
SCIENCE (2003)
Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model
ME Keck et al.
NEUROPSYCHOPHARMACOLOGY (2003)
The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress
DA Gutman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats
ME Keck et al.
PHARMACOPSYCHIATRY (2003)
Regulation of the developing hypothalamic-pituitary-adrenal axis in corticotropin releasing hormone receptor 1-deficient mice
M Schmidt et al.
NEUROSCIENCE (2003)
Impact of high and low anxiety on cognitive performance in a modified hole board test in C57BL/6 and DBA/2 mice
F Ohl et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist
SC Heinrichs et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats
K Ebner et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
The modified hole board as a differential screen for behavior in rodents
F Ohl et al.
BEHAVIOR RESEARCH METHODS INSTRUMENTS & COMPUTERS (2001)
Social defeat as a stressor in humans
K Björkqvist
PHYSIOLOGY & BEHAVIOR (2001)
Animal models of social stress: Effects on behavior and brain neurochemical systems
RJ Blanchard et al.
PHYSIOLOGY & BEHAVIOR (2001)
Dimensions of emotionality in a rat model of innate anxiety
F Ohl et al.
BEHAVIORAL NEUROSCIENCE (2001)
Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment
CM Pariante et al.
BIOLOGICAL PSYCHIATRY (2001)
Stress, hypercortisolism and corticosteroid receptors in depression: implicatons for therapy
F Holsboer
JOURNAL OF AFFECTIVE DISORDERS (2001)
The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats
ME Keck et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation
G Aguilera et al.
REGULATORY PEPTIDES (2000)
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression:: the first 20 patients treated
AW Zobel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
Share Paper
